Naomi Harwin, LCSW | |
10700 Sw Beaverton Hillsdale Hwy Ste 500, Beaverton, OR 97005-3037 | |
(971) 200-1945 | |
Not Available |
Full Name | Naomi Harwin |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 10700 Sw Beaverton Hillsdale Hwy Ste 500, Beaverton, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568030278 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 7508 (Oregon) | Primary |
Entity Name | Naomi Harwin Counseling |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720701105 PECOS PAC ID: 9537536214 Enrollment ID: O20221109002342 |
News Archive
Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today they have licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, today announced top line results from a clinical study showing that the novel inhaled therapeutic, PUR118, demonstrated anti-inflammatory efficacy and was well-tolerated in two Phase 1b studies in patients with chronic obstructive pulmonary disease (COPD).
Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2010. Total revenues for the second quarter of 2010 were $1.93 billion, up 17 percent compared to total revenues of $1.65 billion for the second quarter of 2009. Net income for the second quarter of 2010 was $712.1 million, or $0.79 per diluted share, compared to net income for the second quarter of 2009 of $571.4 million, or $0.61 per diluted share.
Linda Buck, Ph.D., a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, has been named winner of the 2004 Nobel Prize in physiology or medicine.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Naomi Harwin, LCSW 10700 Sw Beaverton Hillsdale Hwy Ste 500, Beaverton, OR 97005-3037 Ph: (971) 200-1945 | Naomi Harwin, LCSW 10700 Sw Beaverton Hillsdale Hwy Ste 500, Beaverton, OR 97005-3037 Ph: (971) 200-1945 |
News Archive
Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today they have licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, today announced top line results from a clinical study showing that the novel inhaled therapeutic, PUR118, demonstrated anti-inflammatory efficacy and was well-tolerated in two Phase 1b studies in patients with chronic obstructive pulmonary disease (COPD).
Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2010. Total revenues for the second quarter of 2010 were $1.93 billion, up 17 percent compared to total revenues of $1.65 billion for the second quarter of 2009. Net income for the second quarter of 2010 was $712.1 million, or $0.79 per diluted share, compared to net income for the second quarter of 2009 of $571.4 million, or $0.61 per diluted share.
Linda Buck, Ph.D., a member of Fred Hutchinson Cancer Research Center's Basic Sciences Division, has been named winner of the 2004 Nobel Prize in physiology or medicine.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
› Verified 8 days ago
Alan Hershman, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14255 Sw Brigadoon Ct Ste 80, Beaverton, OR 97005 Phone: 503-641-1475 | |
Carla E Fadriquela, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2980 Sw 123rd Ave, Beaverton, OR 97005 Phone: 808-281-4616 | |
Tiffanie B Galupi, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1925 Ne Stucki Ave, Beaverton, OR 97006 Phone: 503-906-5000 | |
Stephanie Anne Cox, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6900 Sw 105th Ave Ste B, Beaverton, OR 97008 Phone: 541-638-0830 | |
Ms. Aja Riley Bennett, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 15270 Sw Mallard Dr Ste 101, Beaverton, OR 97007 Phone: 214-454-1447 | |
Tucker Hardy, MSW, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10700 Sw Beaverton Hillsdale Hwy Ste 350, Beaverton, OR 97005 Phone: 971-279-2067 Fax: 971-302-6956 | |
Jessica Edit Villasenor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4537 Sw 96th Ave, Beaverton, OR 97005 Phone: 503-376-9520 |